Faruqi & Faruqi, LLP is investigating claims against Ardelyx for allegedly misleading investors about the commercial performance of its drugs XPHOZAH and IBSRELA. The lawsuit alleges Ardelyx failed to disclose increasing payer restrictions that hurt sales, leading to a sharp stock price drop of about 18% on August 7, 2026, after the company cut its revenue guidance. Investors who bought Ardelyx securities between January 13, 2025, and August 6, 2026, may seek to join the class action or become lead plaintiff by November 16, 2026. The law firm encourages affected investors and whistleblowers to contact them to discuss legal options.
Ardelyx class action lawsuit deadline is November 16, 2026. For readers following the health sector, here is Pluang's market snapshot as of Sep 21, 2026 22:32 WIB: 52 of 95 priced US health stocks rose and 41 fell. Notable movers include TMDX at USD 89.00 (+2.99%), WGS at USD 98.19 (-2.88%), and NVAX at USD 10.40 (+2.87%).
On September 21, 2026, Sandisk was added to the S&P 100 index, replacing Nike, which was removed on the same day. This change reflects shifts in market capitalization and company performance within the index. The update is significant for investors t...
Several top analysts, including Cantor Fitzgerald, Guggenheim, Morgan Stanley, and BTIG Research, have raised price targets and upgraded their outlooks for ServiceNow, signaling confidence in the company's long-term growth. Despite this, the stock ha...
Piper Sandler lowered Colgate-Palmolive's price target to $95 due to weak North American demand and rising competition. The company is responding by focusing on premium oral care innovations, expanding the Fabuloso line, increasing advertising, and c...
MillerKnoll is set to report Q3 2026 earnings with analysts expecting $0.35 EPS and $940.93 million in revenue. The North America Contract segment shows strength with higher prices and volumes, while the Global Retail segment struggles due to tariffs...
Arbitrum's ARB token surged about 151% over the past 30 days, driven by increased activity on Robinhood's second-layer network built on Arbitrum technology and growth in tokenized real-world assets on the platform. Robinhood Chain generates significa...
